Downloads: 10
Informative Article | Biological Sciences | Volume 11 Issue 6, June 2022 | Pages: 1282 - 1285 | India
Leprosy Patients with COVID-19: The Double Trouble?
Abstract: Type 2 leprosy reaction or Erythema nodosum leprosum in conjunction with COVID-19 poses a higher risk for patients with a long course of corticosteroids for its control. Despite regular uptake of corticosteroids, the benefits will usually outweigh the small increase in acquiring SARS-CoV-2 infection. In addition, the actual consequences of M. leprae-SARS-CoV-2 co-infection must be thoroughly investigated. Further detailed work should be done to unleash the factors associated with COVID-19 and their possible correlation with leprosy patients.
Keywords: Leprosy, COVID-19, Erythema nodosum leprosum, Type-2 leprosy reaction, corticosteroids
How to Cite?: Anuj Mavlankar, "Leprosy Patients with COVID-19: The Double Trouble?", Volume 11 Issue 6, June 2022, International Journal of Science and Research (IJSR), Pages: 1282-1285, https://www.ijsr.net/getabstract.php?paperid=SR22617123624, DOI: https://dx.doi.org/10.21275/SR22617123624